Daito Pharmaceutical Co., Ltd. (4577) Press Release
FY2026 4Q Earnings Presentation
Earlier from Daito Pharmaceutical
- Notice Regarding the Results and Completion of the Acquisition of Treasury Shares Through Off-Auction Own Share Repurchase Transaction (ToSTNet-3)
- Summary of Consolidated Financial Results for the Fiscal Year Ended May 31,2026 (Under Japanese GAAP)
- PeptiDream Announces First Dosing of Claudin18.2 Targeting Radiopharmaceutical Candidate 64Cu-PD-29875 in Patients with Gastric Cancer
- Daito Pharmaceutical: Summary of Consolidated Financial Results for the Six Months Ended November 30, 2025 (Under Japanese GAAP)